Burlington, Mass.-based ConforMIS filed documents officially contesting a patent application for a personalized knee replacement system that Stanmore Implants claims to be the world’s 1st.
"ConforMIS strongly disagrees with the recent claim in a press release issued by Stanmore and Imperial Innovations Group that they are developing the ‘world’s first fully personlized early knee replacement surgery system,’ and ConforMIS has filed papers that will help set the record straight," CEO Philip Lang said in prepared remarks.
Imperial Innovations Group, an equity investment firm, gave Stanmore license to patented technology as well as more than $6 million to develop that technology, according to a press release.
"ConforMIS technology related to patient-specific implants and instruments has been in development for more than a decade and ConforMIS has a significant patent portfolio protecting that technology," general counsel and senior vice president of intellectual property David Cerveny said in prepared remarks. "With this filing, ConforMIS has essentially requested that the U.S. Patent & Trademark Office make a determination that ConforMIS inventions in the area predate the work that Imperial Innovations and Stanmore are presently undertaking."